Page 1 of 1

Stem Cell Pharma Inc.

Posted: Sun Sep 02, 2007 7:05 pm
by scoobyjude
MULTIPLE SCLEROSIS, PARKINSON’S DISEASE AND ALS AMONG DISEASES ADDRESSED IN STEM CELL PHARMA INC.’S NEW EXECUTIVE SUMMARY


Las Vegas, Nv. 8/29/2007 5:34 PM GMT (FINDITT)
The following is the new Executive Summary posted on the Stem Cell Pharma, Inc. (SCPI) website.



STEM CELL PHARMA INC. (SCPI)

Stem Cell Pharma Inc. (SCPI) is a privately held bio-pharmaceutical company founded in May of 2005, with a capitalization of 10 mm shares, out of which 3.3mm are issued and outstanding.



SCPI owns the world wide rights to an Invention "An Amniotic Membrane Stem Cell Telomerase Enhanced Implant, Manufacturing And Clinical Uses" by Alfred T. Sapse MD (r) its President and Founder. This invention is a novel approach to harvest embryonic type stem cells from the amniotic membrane, a translucid sheet covering placenta. These embryonic cells can potentially repair and if needed rebuild practically all organs, tissues and cells, through a process of differentiation, once introduced in the human body.



The implant had been used with modest to substantial results in the treatment of neuro degenerative diseases such a Multiple Sclerosis (MS), ALS (Lou Gehrig's Disease), Parkinson's, in eye diseases (Retinitis Pigmentosa - RP, Usher's Syndrome - RP plus deafness), Muscular Dystrophy (MDA) including Duchenne's, children diseases such as Cerebral Palsy (CP) and Epilepsy, autoimmune (Lupus Erythematosus (LE)), and especially in the treatment of symptoms of aging. Clinical studies commenced in the US are now being carried out abroad and some of the results obtained might be used in the United States in the future IND's submissions to the FDA. There were no reports about infections and rejections or any side effects after the use of the implant.

Posted: Sun Sep 02, 2007 9:00 pm
by Lyon
Interesting Judy! I'll look into it further because they specifically mention MS
The implant had been used with modest to substantial results in the treatment of neuro degenerative diseases such a Multiple Sclerosis (MS),
which means some test results must exist somewhere.
Bob

Posted: Wed Sep 05, 2007 6:20 pm
by scoobyjude
I was kind of surprised by the statements-"there were no reports of infection, rejection or side effects". If that's true that's great.

Beware of these folks

Posted: Thu Sep 06, 2007 6:01 am
by art
Beware of these folks - they don't look completely above board. They might just be crappy business folks, but they aren't going about things right. See http://www.acceleratedcure.org:8080/node/2476 and http://www.acceleratedcure.org:8080/node/2059 for a few more details.

Posted: Thu Sep 06, 2007 10:28 am
by TwistedHelix
This puts me in mind of something we discussed quite a long time ago: it involved an old treatment used for generations in Russia which consisted of taking a layer of the amniotic sac and inserting it under the skin, via a V shaped incision, just below the navel. As I recall , it didn't provoke an immune reaction because it is " immune privileged" tissue, and the results claimed for it were remarkable because of the number of foetal stem cells therein. As far as I know, the reports were never substantiated.
This may or may not be similar, but the words " Telomerase enhanced" are interesting: Telomerase is an enzyme which adds Telomeres to the end of chromosomes. Every time a cell divides, it loses a telomere until the count reaches zero, after which it can't divide any more, and dies. If you could enhance this enzyme and add more telomeres it would be possible to extend the life of the cell, (though you wouldn't want to do that indefinitely, because that way lies cancer).
This is just me reading a whole lot into two little words, but it would be pretty significant if this was the case,

Posted: Thu Sep 06, 2007 10:57 am
by dignan
I posted these somewhere else I think, but a couple of other companies that are in the stem cell business and could be worth watching are Pluristem and Neuralstem.

http://www.pluristem.com/09_07_2007.asp

Neuralstem press release